|
Post by Nadica (She/Her) on Jul 19, 2024 22:12:36 GMT
Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic - Published Feb 27, 2022Abstract In this time of COVID-19 pandemic, the strategies for prevention of the infection are a primary concern. Looking more globally on the subject and acknowledging the high degree of misuse of protective face masks from the population, we focused this review on alternative pharmaceutical developments eligible for self-defense against respiratory infections. In particular, the attention herein is directed to the nasal and oromucosal formulations intended to boost the local immunity, neutralize or mechanically “trap” the pathogens at the site of entry (nose or mouth). The current work presents a critical review of the contemporary methods of immune- and chemoprophylaxis and their suitability and applicability in topical mucosal dosage forms for SARS-CoV-2 prophylaxis. Keywords: COVID-19, SARS-CoV-2, respiratory infections, prophylaxis, nasal drug delivery, mucosal drug delivery, protective nasal sprays, protective oral sprays, mucoadhesive dosage forms, antiviral drugs
|
|